Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have received an average recommendation of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the […]
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have received an average recommendation of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a buy recommendation and one has given a strong buy recommendation to the […]
